Consequences of diabetes - Cardiovascular disease

被引：15

作者：

Bloomgarden, ZT ^{[1
]}

机构：

[1] Mt Sinai Sch Med, Ctr Diabet, New York, NY USA

来源：

DIABETES CARE | 2004年 / 27卷 / 07期

关键词：

D O I：

10.2337/diacare.27.7.1825

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1825 / 1831

页数：7

共 27 条

[1] Plasma homocysteine predicts mortality independently of traditional risk factors and C-reactive protein in patients with angiographically defined coronary artery disease [J].

Anderson, JL ;

Muhlestein, JB ;

Horne, BD ;

Carlquist, JF ;

Bair, TL ;

Madsen, TE ;

Pearson, RR .

CIRCULATION, 2000, 102 (11) :1227-1232

[2] Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].

Boaz, M ;

Smetana, S ;

Weinstein, T ;

Matas, Z ;

Gafter, U ;

Iaina, A ;

Knecht, A ;

Weissgarten, Y ;

Brunner, D ;

Fainaru, M ;

Green, MS .

LANCET, 2000, 356 (9237) :1213-1218

[3] Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease [J].

Brown, BG ;

Zhao, XQ ;

Chait, A ;

Fisher, LD ;

Cheung, MC ;

Morse, JS ;

Dowdy, AA ;

Marino, EK ;

Bolson, EL ;

Alaupovic, P ;

Frohlich, J ;

Albers, JJ ;

Serafini, L ;

Huss-Frechette, E ;

Wang, S ;

DeAngelis, D ;

Dodek, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (22) :1583-1592

[4] Homocysteine and risk of ischemic heart disease and stroke -: A meta-analysis [J].

Clarke, R ;

Collins, R ;

Lewington, S ;

Donald, A ;

Alfthan, G ;

Tuomilehto, J ;

Arnesen, E ;

Bonaa, K ;

Blacher, J ;

Boers, GHJ ;

Bostom, A ;

Bots, ML ;

Grobee, DE ;

Brattström, L ;

Breteler, MMB ;

Hofman, A ;

Chambers, JC ;

Kooner, JS ;

Coull, BM ;

Evans, RW ;

Kuller, LH ;

Evers, S ;

Folsom, AR ;

Freyburger, G ;

Parrot, F ;

Genst, J ;

Dalery, K ;

Graham, IM ;

Daly, L ;

Hoogeveen, EK ;

Kostense, PJ ;

Stehouwer, CDA ;

Hopknis, PN ;

Jacques, P ;

Selhub, J ;

Luft, FC ;

Jungers, P ;

Lindgren, A ;

Lolin, YI ;

Loehrer, F ;

Fowler, B ;

Mansoor, MA ;

Malinow, MR ;

Ducimetiere, P ;

Nygard, O ;

Refsum, H ;

Vollset, SE ;

Ueland, PM ;

Omenn, GS ;

Beresford, SAA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (16) :2015-2022

[5]

Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5

[6] Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events? [J].

Cosson, E ;

Guimfack, M ;

Paries, J ;

Paycha, F ;

Attali, JR ;

Valensi, P .

DIABETES & METABOLISM, 2003, 29 (05) :470-476

[7] Serum carotenoids, α-tocopherol and mortality risk in a prospective study among Dutch elderly [J].

De Waart, FG ;

Sehouten, EG ;

Stalenhoef, AFH ;

Kok, FJ .

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2001, 30 (01) :136-143

[8] Effect of vitamins C and E on progression of transplant-associated arteriosclerosis: a randomised trial [J].

Fang, JC ;

Kinlay, S ;

Beltrame, J ;

Hikiti, H ;

Wainstein, M ;

Behrendt, D ;

Suh, J ;

Frei, B ;

Mudge, GH ;

Selwyn, AP ;

Ganz, P .

LANCET, 2002, 359 (9312) :1108-1113

[9] Coronary atherosclerosis in diabetes mellitus - A population-based autopsy study [J].

Goraya, TY ;

Leibson, CL ;

Palumbo, PJ ;

Weston, SA ;

Killian, JM ;

Pfeifer, EA ;

Jacobsen, SJ ;

Frye, RL ;

Roger, VL .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (05) :946-953

[10] Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].

Haffner, SM ;

Lehto, S ;

Rönnemaa, T ;

Pyörälä, K ;

Laakso, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234

← 1 2 3 →